Curvulinic Acid–Gregatin Hybrids with Anti-inflammatory Activity from a Soil-Derived Fungus Penicillium sp. KYS-21
Journal of Natural Products · 2026
DOI: 10.1021/acs.jnatprod.6c00492 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Natural Products, 2026. Verfasst von Du Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong264117, People's Republic of …. Hauptthemen laut MEDLINE: Penicillium, Anti-Inflammatory Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Key R&D Program of Shandong Province, China, Shandong Laboratory Program.
Abstract (Originalsprache)
Chemical investigation of the fungus Penicillium sp. KYS-21 resulted in the isolation of 16 new curvulinic acid–gregatin hybrids (CAGHs), penicurgretides A–P (1–16), together with the only known analogue (17) of this rare class of natural products. Their structures were unambiguously determined by comprehensive spectroscopic analyses, ECD calculations, single-crystal X-ray diffraction, and the modified Mosher’s method. These hybrids exhibit remarkable diversity, featuring a conserved R-configuration at C-5 but variable stereochemistry at other chiral centers. The α,β,γ,δ-unsaturated ketone in the C-5 side chain was established as a critical pharmacophore, as penicurgretides A (1) and G (7), bearing this moiety, exhibited moderate anti-inflammatory activity with IC50 values of 2.94 ± 0.54 and 3.50 ± 0.52 μM, respectively. Mechanistic studies revealed that penicurgretide A (1) suppresses inflammation through inhibition of the NF-κB and mitogen-activated protein kinase signaling pathways, with in vivo efficacy confirmed by reducing nitric oxide and ROS production in an LPS-induced zebrafish model. These findings expand the structural diversity of CAGHs and highlight penicurgretide A (1) as a promising lead for anti-inflammatory drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong264117, People's Republic of China.
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai201203, People's Republic of China.
ORCID-Profile: Xiang-Yu Liu, Jin-Hai Yu, Jian-Min Yue
Förderung
- Key R&D Program of Shandong Province, China
- Shandong Laboratory Program
Zitieren
APA
Chen, D., Liu, X. Y., Li, Y., Fang, C. H., Yu, Z. P., Yu, J. H., & Yue, J. M. (2026). Curvulinic Acid–Gregatin Hybrids with Anti-inflammatory Activity from a Soil-Derived Fungus Penicillium sp. KYS-21. Journal of Natural Products. https://doi.org/10.1021/acs.jnatprod.6c00492
Vancouver
Chen D, Liu XY, Li Y, Fang CH, Yu ZP, Yu JH, et al. Curvulinic Acid–Gregatin Hybrids with Anti-inflammatory Activity from a Soil-Derived Fungus Penicillium sp. KYS-21. Journal of Natural Products. 2026. doi:10.1021/acs.jnatprod.6c00492
BibTeX
@article{Chen2026,
author = {Chen, Du and Liu, Xiang-Yu and Li, Ying and Fang, Chu-Hong and Yu, Zhi-Pu and Yu, Jin-Hai and Yue, Jian-Min},
title = {Curvulinic Acid–Gregatin Hybrids with Anti-inflammatory Activity from a Soil-Derived Fungus Penicillium sp. KYS-21},
journal = {Journal of Natural Products},
year = {2026},
doi = {10.1021/acs.jnatprod.6c00492}
}
EUVIMED